Gilead lands approval of last-hope cancer drug after $12 billion Kite buyout
October 18, 2017 at 19:10 PM EDT
CAR-T therapy is the next great hope for cancer patients, and Gilead has leapfrogged to become an early player in the space.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Home | News | Travel | Restaurants | Nightlife | Things To Do | Shopping | Calendar | Directory | Real Estate | Blog | More
|